ROBERT T VOLPENHEIN
Electrical Contractor at Crescentville Rd, Cincinnati, OH

4518772, May 21, 1985

Jun 23, 1983

6/507826

Robert A. Volpenhein - Cincinnati OH

The Proctor & Gamble Company - Cincinnati OH

C07H 100

536119

An improved solvent-free transesterification process for producing higher polyol fatty acid polyesters is disclosed. In this process a mixture of a polyol, a fatty acid methyl, 2-methoxy ethyl or benzyl ester, an alkali metal fatty acid soap, and a basic catalyst, having a molar ratio of soap:polyol of from about 0. 6:1 to about 1:1, preferably from about 0. 75:1 to about 1:1, is heated to form a homogeneous melt. To this melt is subsequently added excess fatty acid methyl, 2-methoxy ethyl or benzyl ester, yielding the desired polyol fatty acid polyesters.

4582715, Apr 15, 1986

Dec 4, 1984

6/677787

Robert A. Volpenhein - Cincinnati OH

The Procter & Gamble Company - Cincinnati OH

A23D 300, A23D 500

426601

alpha-Acylated glycerides having the formula: ##STR1## wherein each R. sup. 1 is a C. sub. 10 -C. sub. 14 alkyl group and wherein each R. sup. 2 is a C. sub. 14 -C. sub. 16 aliphatic group are disclosed. These alpha-acylated glycerides are useful as non-digestible fats in low calorie fat-containing food compositions.

4517360, May 14, 1985

Jun 23, 1983

6/507825

Robert A. Volpenhein - Cincinnati OH

The Procter & Gamble Company - Cincinnati OH

C07H 100

536119

An improved solvent-free transesterification process for producing polyol fatty acid polyesters is disclosed. In this process, a mixture of a polyol, a fatty acid methyl, 2-methoxy ethyl or benzyl ester, an alkali metal fatty acid soap, and potassium carbonate, sodium carbonate or barium carbonate as a catalyst is heated to form a homogeneous melt. To this melt is subsequently added excess fatty acid methyl, 2-methoxy ethyl or benzyl ester, yielding the desired polyol fatty acid polyesters.

4263216, Apr 21, 1981

Oct 20, 1978

5/953303

Robert A. Volpenhein - Cincinnati OH

The Procter & Gamble Company - Cincinnati OH

C11C 302

2604107

Saturated triglycerides are reacted with glycerol in the presence of either a glycerolysis catalyst or a pre-formed glycerate to provide a product which is a mixture of monoglycerides, triglycerides, 1,2-diglycerides and 1,3-diglycerides. The mixture is stored in the presence of a low temperature rearrangement catalyst at a storage temperature below the melting point of the glyceride ester components of the mixture and substantially all of the mixture is converted into 1,3-diglycerides. In this way there are prepared, for example, 1-palmitoyl,3-stearoyl diglyceride, 1,3-distearoyl diglyceride and 1,3-dipalmitoyl diglyceride, which are appropriate precursors for the synthesis of confectioner's hard butters, and the like.

3954976, May 4, 1976

Dec 14, 1973

5/425010

Fred Hugh Mattson - Cincinnati OH
Robert Anthony Volpenhein - Cincinnati OH

The Procter & Gamble Company - Cincinnati OH

A01N 900

424180

Pharmaceutical compositions for inhibiting the absorption of cholesterol comprising effective unit dosage amounts of a polyol fatty acid ester having at least four fatty acid ester groups; and a method for treating and/or preventing hypercholesterolemia in an animal comprising systematically administering to such animal successive therapeutically effective doses of said polyol fatty acid ester.

4241054, Dec 23, 1980

Dec 8, 1978

5/967658

Robert A. Volpenhein - Cincinnati OH
Ronald J. Jandacek - Cincinnati OH

The Procter & Gamble Company - Cincinnati OH

A61K 3170

424180

Non-absorbable polyol polyesters dissolve toxic lipophilic compounds in the stomach and intestine of humans and lower animals and thus decrease their absorption. The polyol polyesters also dissolve the toxic, lipophilic materials and their metabolites if they are excreted in bile, and prevent their resorption. The invention thus provides a means for detoxifying humans and lower animals which have ingested toxic lipophilic materials (e. g. , DDT, Kepone, PCB, PBB) by accelerating the excretion of such materials that have accumulated in the body. The process involves oral administration to a human or lower animal in need of such treatment of a sufficient amount of a non-absorbable polyol fatty acid polyester to effect detoxification.